Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation.
about
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugsStatin use and cancer risk: an epidemiologic review.The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.The effects of statin medications on aerobic exercise capacity and training adaptations.Modeling cholesterol metabolism by gene expression profiling in the hippocampus.Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
P2860
Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@ast
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@en
type
label
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@ast
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@en
prefLabel
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@ast
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@en
P356
P1433
P1476
Suppression of dolichol synthe ...... cacy of IGF-I down-regulation.
@en
P356
10.1054/MEHY.2000.1073
P577
2001-01-01T00:00:00Z